Navigation Links
Pharmaceutical Strategic Initiatives Adds Anne Sexton, MD, MS to Management Team
Date:3/31/2008

DURHAM, N.C., March 31 /PRNewswire/ -- Pharmaceutical Strategic Initiatives (PSI), a provider of marketing consultation and content development services to the pharmaceutical industry, has added Anne L. Sexton MD, MS to its management team as Vice President of Medical Activities.

Dr. Sexton brings 15 years of clinical and pharmaceutical experience to PSI. Dr. Sexton's broad experience includes medical affairs and medical monitoring, drug development strategy, regulatory affairs activities including FDA submissions, drug safety/pharmacovigilance and medical writing.

According to PSI President Charles Carter, PhD, "Anne brings the clinical and industry experience our customers need to develop and implement their integrated medical affairs strategies and support regulatory initiatives."

Prior to joining PSI, Dr. Sexton headed an independent consulting company serving the pharmaceutical and biotech industries.

About Pharmaceutical Strategic Initiatives

PSI was founded in 1988 by Charles Carter, PharmD, MBA and is part of Interactive Holdings. PSI provides strategic marketing consultation and content development services to the pharmaceutical industry. For more information about PSI, contact Mary Messina at 919.314.1380 or visit http://www.psillc.com.


'/>"/>
SOURCE Pharmaceutical Strategic Initiatives
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
2. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
3. China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results
4. Barr Pharmaceuticals, Inc. Executive Bios
5. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
6. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
7. Honeywell Expands Aclar(R) Production for Pharmaceutical Industry
8. Surveys Find Key Changes in the Role of the Pharmaceutical CFO
9. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
10. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
11. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid ... Thyroid Secret. Dr. Wentz talked about journey and research recently on a blog and ... NOT the only solution to deal with thyroid disease. , Dr. Wentz completed ...
(Date:3/28/2017)... ... ... Alert Sentry Group LLC., a leader in the Personal Emergency Response System ... the iSAFE Plus. These iSAFE products are the most affordable and most advanced medical ... Plus offer direct GPS Location and two-way calling with the push of a button ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, ... ensuring high-quality results and maintaining GMP and USP compliance. In a new webinar ... with GMP requirements " these requirements are explained. The challenge is to ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
(Date:3/28/2017)... ... March 28, 2017 , ... AutismOne announced the Board Certified ... Integrative Medicine and available for application on Saturday, May 27, 2017, following Thursday, ... Colorado Springs. , Ed Arranga, president of AutismOne, stated: "Many of the modalities ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  CASI Pharmaceuticals, ... innovative therapeutics addressing cancer and other unmet medical ... American Association for Cancer Research annual meeting.  The ... is entitled "Evaluation of ENMD-2076 in Combination ... the second poster to be presented on April ...
(Date:3/28/2017)... 28, 2017 The global ... 8.0 billion by 2025, according to a new study ... infectious diseases and cancer is expected to upsurge the ... over the coming years. In addition, higher number of ... allogenic stem cell therapy, due to adverse effects caused ...
(Date:3/27/2017)... , March 27, 2017 The National ... health and data analytics company, signed a Memorandum ... improving healthcare delivery in the region. ... Global Health Research and Technology (BIGHEART) at NUS ... several topics related to healthcare IT and medical ...
Breaking Medicine Technology: